Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Background: ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and reduced responsiveness to standard therapies. Although specific ErbB2-targeted therapies have been...